Malignancies associated with BRCA 1 and 2 include all of the following except?
Which gene is involved in Retinoblastoma?
Russel bodies are seen in which of the following conditions?
Which of the following is the most common tumor of the fetus and newborn?
Tumor arising from a totipotent cell is:
Which of the following malignancies is associated with the characteristic Zellballen pattern on histopathology?
Which tumor suppressor gene is primarily responsible for lung squamous cell carcinoma?
Microdeletion leading to instability of DNA, causing the cell to undergo degeneration, is seen as a marker in which of the following cancers?
MIC-2 is a marker of?
Smoking is most commonly associated with which of the following carcinomas?
Explanation: **Explanation:** The **BRCA1 and BRCA2** genes are tumor suppressor genes involved in the repair of double-stranded DNA breaks via **homologous recombination**. Mutations in these genes lead to genomic instability, significantly increasing the risk of various malignancies. **Why Mesothelioma is the correct answer:** **Mesothelioma** is primarily associated with **asbestos exposure** [1] and mutations in the **BAP1 gene** (BRCA1-associated protein 1), not the BRCA1/2 genes themselves. While BAP1 is part of the same molecular pathway, standard BRCA1/2 germline mutations are not established risk factors for mesothelioma. **Analysis of other options:** * **Breast Cancer:** This is the most common association. BRCA1 carries a higher lifetime risk (up to 80%) [3] and is often associated with "triple-negative" tumors, while BRCA2 is associated with ER-positive tumors and **male breast cancer**. * **Prostate Cancer:** BRCA2 mutations, in particular, are linked to an increased risk of aggressive, high-grade prostate cancer in men. * **Papillary Serous Carcinoma of Peritoneum:** BRCA mutations predispose individuals to serous carcinomas of the "Müllerian" spectrum, which includes the ovaries, fallopian tubes, and the primary peritoneum. **High-Yield Clinical Pearls for NEET-PG:** * **Chromosome Locations:** BRCA1 is on **Ch 17q**, and BRCA2 is on **Ch 13q**. * **Pancreatic Cancer:** BRCA2 is a significant risk factor for familial pancreatic adenocarcinoma [2]. * **Ovarian Cancer:** BRCA1 carries a higher risk (approx. 40%) compared to BRCA2 (approx. 15%). * **Synthetic Lethality:** Tumors with BRCA mutations are highly sensitive to **PARP inhibitors** (e.g., Olaparib). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 221-222. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 898-899. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, pp. 1058-1060.
Explanation: **Explanation:** The **RB1 gene**, the first tumor suppressor gene ever discovered, is located on the long arm of **chromosome 13 at region 1, band 4 (13q14)** [1]. **1. Why 13q14 is correct:** The RB1 gene encodes the pRB protein, which acts as a critical "brake" on the cell cycle [3]. It prevents the transition from the G1 to the S phase by binding and sequestering the **E2F transcription factor** [4]. When both alleles of the RB1 gene are inactivated (Knudson’s "Two-Hit" Hypothesis), E2F is released, leading to uncontrolled cell proliferation and the development of Retinoblastoma [1], [2]. **2. Analysis of Incorrect Options:** * **12p13:** This locus is associated with the *ETV6* gene, often involved in leukemias (e.g., ETV6-RUNX1 translocation in ALL). * **13p14:** This refers to the short arm (p) of chromosome 13. The RB1 gene is specifically located on the long arm (q). * **12q13:** This locus is associated with the *MDM2* gene (an inhibitor of p53) and is frequently amplified in well-differentiated liposarcomas. **3. High-Yield Clinical Pearls for NEET-PG:** * **Knudson’s Two-Hit Hypothesis:** In familial cases, the first hit is germline (inherited), and the second is somatic. In sporadic cases, both hits are somatic [1]. * **Histology:** Look for **Flexner-Wintersteiner rosettes** (pathognomonic) and **Homer Wright rosettes**. * **Clinical Sign:** The most common presenting sign is **Leukocoria** (white pupillary reflex). * **Secondary Tumors:** Patients with germline RB1 mutations have a high risk of developing **Osteosarcoma** later in life. * **Trilateral Retinoblastoma:** Bilateral retinoblastoma associated with a pineal tumor (Pineoblastoma). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 300. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-298. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 300-301.
Explanation: **Explanation:** **Russell bodies** are large, eosinophilic, homogeneous immunoglobulin inclusions found within the cytoplasm of plasma cells. They represent an accumulation of newly synthesized immunoglobulins in the **Rough Endoplasmic Reticulum (RER)**, occurring when the rate of protein synthesis exceeds the cell's capacity to secrete them. This is a classic example of intracellular protein accumulation. * **Option A (Correct):** In **Multiple Myeloma**, there is a neoplastic proliferation of plasma cells producing excessive monoclonal antibodies [1]. These cells frequently exhibit Russell bodies. When these inclusions are found within the nucleus, they are termed **Dutcher bodies**. * **Option B (Incorrect):** Rabies is characterized by **Negri bodies**, which are eosinophilic cytoplasmic inclusions found in pyramidal cells of the hippocampus and Purkinje cells of the cerebellum. * **Option C (Incorrect):** Parkinsonism is associated with **Lewy bodies**, which are eosinophilic cytoplasmic inclusions containing alpha-synuclein found in the neurons of the substantia nigra. * **Option D (Incorrect):** While various inclusions exist in CNS tumors (e.g., Psammoma bodies in Meningiomas), Russell bodies are not a characteristic feature of intracranial neoplasms. **High-Yield Clinical Pearls for NEET-PG:** * **Mott Cells:** A plasma cell containing multiple Russell bodies is called a "Mott cell" or "Grape cell." * **Dutcher vs. Russell:** Remember: **R**ussell = **R**ER (Cytoplasm); **D**utcher = **D**irectly in nucleus. * **Flame Cells:** Bright red cytoplasm in plasma cells (seen in IgA Myeloma) [2]. * **Bence-Jones Proteins:** Free light chains excreted in the urine of Myeloma patients, which precipitate at 40-60°C and redissolve at 100°C [1], [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 606-608. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 616-619.
Explanation: **Explanation:** **Sacrococcygeal Teratoma (SCT)** is the most common tumor of the fetus and newborn [1], occurring in approximately 1 in 20,000 to 40,000 live births [1]. These tumors arise from the **totipotent cells** of the primitive streak (Hensen’s node) that fail to migrate or involute. They are more common in females (4:1 ratio) [1]. While most are benign (mature), the risk of malignancy increases with age at diagnosis. **Analysis of Incorrect Options:** * **Neuroblastoma:** This is the most common **extracranial solid tumor of childhood** and the most common malignancy in infants (under 1 year), but it is not more frequent than SCT in the immediate neonatal/fetal period. * **Wilms Tumor (Nephroblastoma):** This is the most common **primary renal tumor of childhood**, typically presenting between ages 2 and 5. It is rare in the neonatal period. * **Leukemia:** While leukemia is the most common childhood cancer overall, it is not the most common tumor at birth. Congenital leukemia is a rare entity. **High-Yield Clinical Pearls for NEET-PG:** * **Altman Classification:** Used for SCT based on the location (Type I is predominantly external; Type IV is entirely presacral/internal). * **Tumor Markers:** Elevated **Alpha-fetoprotein (AFP)** in a teratoma often suggests a yolk sac component (malignancy). * **Associated Complication:** Large fetal SCTs can cause **high-output cardiac failure** and hydrops fetalis due to significant vascular shunting (steal phenomenon). * **Most common malignancy in infants:** Neuroblastoma. * **Most common childhood cancer:** Acute Lymphoblastic Leukemia (ALL). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 482-483.
Explanation: **Explanation:** **1. Why Teratoma is the Correct Answer:** A **Teratoma** is a germ cell tumor derived from **totipotent cells** (typically found in the ovary or testis) [1]. Totipotent cells have the unique capacity to differentiate into any of the three germ layers: **ectoderm, mesoderm, and endoderm** [3]. Consequently, a teratoma characteristically contains a variety of tissues foreign to the organ in which it arises, such as hair, teeth (ectoderm), muscle, bone (mesoderm), and gut epithelium (endoderm) [2]. **2. Analysis of Incorrect Options:** * **Seminoma (Option B):** While this is also a germ cell tumor, it is composed of a single, uniform population of undifferentiated germ cells [5]. It does not exhibit the multi-lineage differentiation characteristic of totipotent cells. * **Myoma (Option C):** This is a benign tumor of muscle tissue (e.g., Leiomyoma from smooth muscle). It is a specialized mesenchymal tumor, not derived from totipotent cells. * **Lipoma (Option D):** This is a benign tumor of adipocytes (fat cells). Like myoma, it is a differentiated mesenchymal tumor. **3. NEET-PG High-Yield Pearls:** * **Classification:** Teratomas are classified into **Mature** (well-differentiated, usually benign in females) and **Immature** (contains fetal/neuroepithelial tissue, potentially malignant) [3]. * **Monodermal Teratomas:** Highly specialized forms include **Struma ovarii** (composed of thyroid tissue) and **Carcinoid** [4]. * **Most Common Site:** The most common location for a teratoma in infants is the **sacrococcygeal region**. * **Dermoid Cyst:** A common term for a mature cystic teratoma of the ovary, typically lined by skin-like structures [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Female Genital Tract Disease, pp. 480-481. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 276. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1033-1034. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, p. 1034. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 979-980.
Explanation: **Explanation:** The correct answer is **C. Carotid body tumor**. **1. Why Carotid Body Tumor is correct:** A carotid body tumor is a type of **paraganglioma** (extra-adrenal pheochromocytoma) [1]. The characteristic histopathological hallmark of paragangliomas is the **Zellballen pattern**. This consists of nests or clusters of round-to-oval neuroendocrine cells (Chief cells) surrounded by a delicate vascular stroma and peripheral spindle-shaped sustentacular cells. The term "Zellballen" is German for "cell balls." **2. Why other options are incorrect:** * **A. Gastrointestinal stromal tumor (GIST):** Characterized by bundles of spindle cells or epithelioid cells. The diagnostic marker is **CD117 (c-KIT)**. * **B. Astrocytoma:** Low-grade astrocytomas show a fibrillary background; high-grade (GBM) shows pseudopalisading necrosis. They do not form nested patterns. * **C. Retinoblastoma:** Characterized by **Flexner-Wintersteiner rosettes** (true rosettes with a central lumen) and Homer Wright rosettes. **3. High-Yield Clinical Pearls for NEET-PG:** * **Location:** Carotid body tumors occur at the bifurcation of the common carotid artery [1]. * **Clinical Sign:** **Fontaine’s Sign** – The mass is mobile horizontally but fixed vertically (due to its attachment to the carotid artery). * **Immunohistochemistry (IHC):** Chief cells are positive for **Synaptophysin/Chromogranin**, while Sustentacular cells are positive for **S-100**. * **Rule of 10s:** While traditionally associated with pheochromocytoma, remember that carotid body tumors are the most common head and neck paragangliomas [1]. * **Salt and Pepper Chromatin:** A common feature of neuroendocrine tumors, including the cells within the Zellballen nests. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 748-749.
Explanation: **Explanation:** **Correct Answer: A. p53** The **TP53 gene** (located on chromosome 17p) is the most frequently mutated gene in human cancers [3]. In the context of lung cancer, p53 mutations are strongly associated with exposure to tobacco smoke [2]. It is found in over **90% of Small Cell Lung Carcinomas (SCLC)** and approximately **50-80% of Squamous Cell Carcinomas (SCC)** [1]. The mutation often occurs early in the pathogenesis of squamous cell carcinoma, following the initial stages of squamous metaplasia and dysplasia [1]. **Analysis of Incorrect Options:** * **B. Rb (Retinoblastoma gene):** While Rb mutations are nearly universal in **Small Cell Lung Carcinoma (SCLC)** (approx. 90%), they are less frequent in Squamous Cell Carcinoma compared to p53 [1]. * **C. PTEN:** This tumor suppressor is more classically associated with **Endometrial carcinoma**, Glioblastoma, and Prostate cancer. In the lung, it is less common than p53 or CDKN2A mutations. * **D. p63:** This is not a tumor suppressor gene responsible for the *initiation* of the cancer; rather, it is a **diagnostic immunohistochemical (IHC) marker**. p63 (along with CK5/6 and P40) is used to confirm the squamous lineage of a poorly differentiated lung tumor. **High-Yield Clinical Pearls for NEET-PG:** * **Squamous Cell Carcinoma (SCC):** Centrally located, associated with smoking, and may cause **Hypercalcemia** (due to PTHrP production). * **Adenocarcinoma:** Most common type in **non-smokers** and females; typically peripheral; associated with **EGFR** and **ALK** mutations. * **Small Cell Carcinoma:** Strongest link to smoking; neuroendocrine origin; associated with **p53 and Rb** mutations [1]. * **Molecular Marker for SCC:** Loss of **CDKN2A (p16)** is also a very common early event in lung SCC [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, p. 721. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 331-332. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 301-302.
Explanation: ### Explanation The correct answer is **Colon carcinoma**. The question refers to **Microsatellite Instability (MSI)**, a hallmark of the **Mismatch Repair (MMR) pathway** defect [1]. Microsatellites are short, repetitive DNA sequences prone to errors (insertions or deletions) during replication. Normally, MMR genes (MLH1, MSH2, MSH6, PMS2) correct these errors [1]. A deficiency in these genes leads to the accumulation of mutations (microdeletions/instability), driving oncogenesis [1]. This is the underlying mechanism in **Lynch Syndrome** (Hereditary Non-Polyposis Colorectal Cancer - HNPCC) and approximately 15% of sporadic colorectal cancers [1], [2]. #### Analysis of Options: * **Colon Carcinoma (Correct):** MSI is a classic molecular marker for colorectal cancer [1]. These tumors often arise in the right colon, show a mucinous histology, and paradoxically have a better prognosis despite being high-grade [1]. * **Medullary Carcinoma of Thyroid:** This is associated with **RET proto-oncogene** mutations (MEN 2A/2B), not DNA repair instability. * **Small Cell Lung Cancer:** Characterized by strong associations with smoking and mutations/deletions in **RB1** and **TP53** genes. * **Gastric Lymphoma:** Most commonly MALToma, which is associated with *H. pylori* infection and specific translocations like **t(11;18)**. #### NEET-PG High-Yield Pearls: * **Lynch Syndrome:** Autosomal dominant; most common mutated genes are **MSH2** and **MLH1** [3]. * **Screening:** MSI status is now routinely tested in colon cancers via immunohistochemistry (IHC) for MMR proteins [1]. * **Prognostic Value:** MSI-High (MSI-H) colorectal cancers generally have a better prognosis but respond poorly to 5-Fluorouracil (5-FU) monotherapy [1]. * **Amsterdam Criteria:** Used clinically to identify families at risk for Lynch Syndrome (3-2-1 rule: 3 relatives, 2 generations, 1 diagnosed before age 50). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 819-821. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 373-374. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 817.
Explanation: **Explanation:** **MIC-2** (also known as **CD99**) is a cell surface glycoprotein that is highly characteristic of the **Ewing Sarcoma/Primitive Neuroectodermal Tumor (PNET)** family. It is encoded by the *MIC2* gene located on the pseudoautosomal region of the X and Y chromosomes. 1. **Why Ewing Sarcoma is Correct:** In Ewing Sarcoma, MIC-2/CD99 shows a distinctive **strong, diffuse, membranous staining** pattern on immunohistochemistry (IHC). While not 100% specific, it is a highly sensitive marker used to differentiate Ewing sarcoma from other "small round blue cell tumors" of childhood. 2. **Why Other Options are Incorrect:** * **Chronic Lymphocytic Leukemia (CLL):** The hallmark markers for CLL are **CD5, CD19, CD20, and CD23**. MIC-2 is not used for its diagnosis. * **Mantle Cell Lymphoma (MCL):** MCL is characterized by the overexpression of **Cyclin D1** (due to t(11;14)) and markers like **CD5** and **SOX11** [1]. 3. **High-Yield Clinical Pearls for NEET-PG:** * **Genetics:** Ewing Sarcoma is most commonly associated with **t(11;22)(q24;q12)**, leading to the **EWS-FLI1** fusion gene. * **Radiology:** Classically presents with an **"onion-skin"** periosteal reaction. * **Morphology:** Small round blue cells with scant cytoplasm; **Homer-Wright rosettes** may be seen (indicating neural differentiation). * **Differential Diagnosis:** Other CD99-positive tumors include lymphoblastic lymphoma and synovial sarcoma, but in the context of bone tumors, it strongly points to Ewing's. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 610-612.
Explanation: **Explanation:** **1. Why Urinary Bladder Carcinoma is correct:** Smoking is the most significant risk factor for **Urothelial (Transitional Cell) Carcinoma** of the bladder, accounting for approximately 50% of cases [1]. Cigarettes contain aromatic amines (such as **beta-naphthylamine**) and polycyclic aromatic hydrocarbons [3]. These carcinogens are absorbed into the bloodstream, filtered by the kidneys, and concentrated in the urine [1]. Prolonged contact between these metabolites and the bladder mucosa leads to field cancerization and malignant transformation. **2. Why the other options are incorrect:** * **Liver Carcinoma:** The primary risk factors are chronic Hepatitis B/C infections, cirrhosis, and Aflatoxin exposure. While smoking is a minor cofactor, it is not the primary association. * **Gallbladder Carcinoma:** This is most strongly associated with **cholelithiasis** (gallstones) and "porcelain gallbladder." * **Stomach Carcinoma:** The strongest associations are with *H. pylori* infection, dietary nitrosamines (smoked/salted foods), and genetic factors (CDH1 mutation) [2]. **3. NEET-PG High-Yield Pearls:** * **Most common type:** Smoking specifically increases the risk of **Transitional Cell Carcinoma (TCC)** [1]. * **Occupational Risk:** Workers in the **dye, rubber, and leather industries** are at high risk due to aniline dye exposure [2]. * **Schistosomiasis:** Infection with *S. haematobium* is specifically associated with **Squamous Cell Carcinoma** of the bladder, not TCC [1]. * **Field Cancerization:** This concept explains why patients with bladder cancer are also at risk for synchronous or metachronous tumors in the ureter or renal pelvis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 968-970. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 217-218. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 423-424.
Nomenclature and Classification of Tumors
Practice Questions
Characteristics of Benign and Malignant Neoplasms
Practice Questions
Molecular Basis of Cancer
Practice Questions
Carcinogenesis and Carcinogens
Practice Questions
Tumor Progression and Metastasis
Practice Questions
Tumor Markers
Practice Questions
Paraneoplastic Syndromes
Practice Questions
Genetic Basis of Cancer
Practice Questions
Tumor Immunity
Practice Questions
Cancer Epidemiology and Prevention
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free